General MedicationsINTRAVENOUSStandard
BRIVARACETAM
BRIVARACETAM
Standard Dose
50MG/5ML (10MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview BRIVARACETAM is listed in Drugs@FDA under application 218249 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient BRIVARACETAM Form and strength SOLUTION;INTRAVENOUS - 50MG/5ML (10MG/ML) Sponsor HAINAN POLY Submission history Latest submission status date: 2026-02-23 00:00:00.
Structured Monograph
Clinical summary
Approval overview BRIVARACETAM is listed in Drugs@FDA under application 218249 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient BRIVARACETAM Form and strength SOLUTION;INTRAVENOUS - 50MG/5ML (10MG/ML) Sponsor HAINAN POLY Submission history Latest submission status date: 2026-02-23 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.